tetano
Editor, Senior Moderator
Infect Dis (Lond)
. 2022 May 6;1-15.
doi: 10.1080/23744235.2022.2070273. Online ahead of print.
Cytomegalovirus coinfection in patients with severe acute respiratory syndrome coronavirus 2 infection: a systematic review of reported cases
Ehsan Taherifard[SUP] 1 [/SUP], Hamed Movahed[SUP] 1 [/SUP], Sima Kiani Salmi[SUP] 2 [/SUP], Ali Taherifard[SUP] 2 [/SUP], Saeed Abdollahifard[SUP] 3 4 [/SUP], Erfan Taherifard[SUP] 1 [/SUP]
Affiliations
Abstract
Background: Dysfunction of both the innate and the adaptive immune systems is observed in severe coronavirus disease 2019 which, together with administration of immunosuppressive drugs, could lead to cytomegalovirus coinfection or reactivation associated with a poorer outcome. The current study aimed to systematically review the pattern, presentations, clinical course and outcome of patients with severe acute respiratory syndrome coronavirus 2 and cytomegalovirus coinfection.
Methods: Three online databases, PubMed, Scopus and Web of Science, were searched, and after excluding duplicates and irrelevant reports, eligible articles were identified. Information about patients' age and gender, comorbidities, presentations of coronavirus disease 2019 and cytomegalovirus, treatment courses and outcomes were extracted.
Results: A total of 34 reports with 59 patients with coinfection were considered to be eligible for data extraction. A majority of patients were middle-aged or elderly (84.5%). More than three-fourths (79.2%) had at least one comorbidity. Cytomegalovirus viremia was documented in 43 patients. The most common end organ involved was the gastrointestinal tract in 13 patients (48.1% of 27 patients with end organ involvement), mostly as cytomegalovirus colitis, followed by the respiratory tract in 12 patients. There was a significant association between intubation and fatal outcome (p = .011).
Conclusion: We comprehensively reviewed published cases with coronavirus disease 2019 and cytomegalovirus reactivation. The findings may assist in appraising signs and symptoms for early suspicion, detection and treatment in patients with unusual clinical courses or with severe, prolonged or unexplained deterioration of end organ function.
Keywords: COVID-19; SARS-CoV-2; cytomegalovirus.
. 2022 May 6;1-15.
doi: 10.1080/23744235.2022.2070273. Online ahead of print.
Cytomegalovirus coinfection in patients with severe acute respiratory syndrome coronavirus 2 infection: a systematic review of reported cases
Ehsan Taherifard[SUP] 1 [/SUP], Hamed Movahed[SUP] 1 [/SUP], Sima Kiani Salmi[SUP] 2 [/SUP], Ali Taherifard[SUP] 2 [/SUP], Saeed Abdollahifard[SUP] 3 4 [/SUP], Erfan Taherifard[SUP] 1 [/SUP]
Affiliations
- PMID: 35522073
- DOI: 10.1080/23744235.2022.2070273
Abstract
Background: Dysfunction of both the innate and the adaptive immune systems is observed in severe coronavirus disease 2019 which, together with administration of immunosuppressive drugs, could lead to cytomegalovirus coinfection or reactivation associated with a poorer outcome. The current study aimed to systematically review the pattern, presentations, clinical course and outcome of patients with severe acute respiratory syndrome coronavirus 2 and cytomegalovirus coinfection.
Methods: Three online databases, PubMed, Scopus and Web of Science, were searched, and after excluding duplicates and irrelevant reports, eligible articles were identified. Information about patients' age and gender, comorbidities, presentations of coronavirus disease 2019 and cytomegalovirus, treatment courses and outcomes were extracted.
Results: A total of 34 reports with 59 patients with coinfection were considered to be eligible for data extraction. A majority of patients were middle-aged or elderly (84.5%). More than three-fourths (79.2%) had at least one comorbidity. Cytomegalovirus viremia was documented in 43 patients. The most common end organ involved was the gastrointestinal tract in 13 patients (48.1% of 27 patients with end organ involvement), mostly as cytomegalovirus colitis, followed by the respiratory tract in 12 patients. There was a significant association between intubation and fatal outcome (p = .011).
Conclusion: We comprehensively reviewed published cases with coronavirus disease 2019 and cytomegalovirus reactivation. The findings may assist in appraising signs and symptoms for early suspicion, detection and treatment in patients with unusual clinical courses or with severe, prolonged or unexplained deterioration of end organ function.
Keywords: COVID-19; SARS-CoV-2; cytomegalovirus.